Merck Says Ax Of $2.5B Patent Win A 'Disaster For Innovation'
Merck & Co.'s Idenix subsidiary urged the full Federal Circuit on Wednesday to reconsider a decision that wiped out a $2.5 billion verdict in a patent dispute with Gilead Sciences Inc.,...To view the full article, register now.
Already a subscriber? Click here to view full article